drug_name,chembl_id,mechanism_of_actions,smiles
HYDROXYUREA,CHEMBL467,Ribonucleoside-diphosphate reductase RR1 inhibitor,NC(=O)NO
SUNITINIB,CHEMBL535,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor beta inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
CYTARABINE,CHEMBL803,DNA inhibitor | DNA polymerase (alpha/delta/epsilon) inhibitor | RNA inhibitor,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
TARIQUIDAR,CHEMBL348475,P-glycoprotein 1 inhibitor,COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2
DASATINIB ANHYDROUS,CHEMBL1421,Bcr/Abl fusion protein inhibitor | Ephrin type-A receptor 2 inhibitor | Platelet-derived growth factor receptor beta inhibitor | SRC inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase ABL inhibitor,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
SUNITINIB MALATE,CHEMBL1567,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor inhibitor,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O
GEMCITABINE HYDROCHLORIDE,CHEMBL1637,DNA polymerase (alpha/delta/epsilon) inhibitor | Ribonucleoside-diphosphate reductase RR1 inhibitor,Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
IMATINIB MESYLATE,CHEMBL1642,Bcr/Abl fusion protein inhibitor | Platelet-derived growth factor receptor beta inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase ABL inhibitor,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
ZOSUQUIDAR,CHEMBL444172,P-glycoprotein 1 inhibitor,O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1
CLOFARABINE,CHEMBL1750,DNA inhibitor | DNA polymerase (alpha/delta/epsilon) inhibitor | Ribonucleoside-diphosphate reductase RR1 inhibitor,Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F
FLUDARABINE PHOSPHATE,CHEMBL1096882,DNA polymerase (alpha/delta/epsilon) inhibitor | Ribonucleoside-diphosphate reductase RR1 inhibitor,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@@H]1O
VALSPODAR,CHEMBL1086218,P-glycoprotein 1 inhibitor,C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
SORAFENIB TOSYLATE,CHEMBL1200485,Platelet-derived growth factor receptor beta inhibitor | Serine/threonine-protein kinase B-raf inhibitor | Serine/threonine-protein kinase RAF inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor inhibitor,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1
GALLIUM NITRATE,CHEMBL1200983,Ribonucleoside-diphosphate reductase RR1 inhibitor,
PAZOPANIB HYDROCHLORIDE,CHEMBL1201733,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl
VEMURAFENIB,CHEMBL1229517,Serine/threonine-protein kinase B-raf inhibitor,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F
REGORAFENIB,CHEMBL1946170,Ephrin type-A receptor 2 inhibitor | Platelet-derived growth factor receptor inhibitor | Serine/threonine-protein kinase B-raf inhibitor | Serine/threonine-protein kinase RAF inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase ABL inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor inhibitor,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
DABRAFENIB MESYLATE,CHEMBL2105729,Serine/threonine-protein kinase B-raf inhibitor,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O
TIVOZANIB HYDROCHLORIDE,CHEMBL2105756,Platelet-derived growth factor receptor beta inhibitor | Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O
ENCORAFENIB,CHEMBL3301612,Serine/threonine-protein kinase B-raf inhibitor,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1
MOTEXAFIN GADOLINIUM,CHEMBL3544910,Ribonucleoside-diphosphate reductase RR1 inhibitor,
CM-082,CHEMBL3545427,Platelet-derived growth factor receptor beta inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,
CATEQUENTINIB,CHEMBL4303201,Platelet-derived growth factor receptor beta inhibitor | Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1
ENCEQUIDAR,CHEMBL4594298,P-glycoprotein 1 inhibitor,COc1cc2c(cc1OC)CN(CCc1ccc(-n3nnc(-c4cc(OC)c(OC)cc4NC(=O)c4cc(=O)c5ccccc5o4)n3)cc1)CC2
SEMAXANIB,CHEMBL276711,Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
VANDETANIB,CHEMBL24828,Tyrosine-protein kinase SRC inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor inhibitor,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1
VATALANIB,CHEMBL101253,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
LINIFANIB,CHEMBL223360,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Vascular endothelial growth factor receptor inhibitor,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1
CEDIRANIB,CHEMBL491473,Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1
DOVITINIB,CHEMBL522892,Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Vascular endothelial growth factor receptor inhibitor,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1
MOTESANIB,CHEMBL572881,Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor RET inhibitor | Vascular endothelial growth factor receptor inhibitor,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21
QUIZARTINIB,CHEMBL576982,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor RET inhibitor,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
LESTAURTINIB,CHEMBL603469,Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor RET inhibitor,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
MIDOSTAURIN,CHEMBL608533,Platelet-derived growth factor receptor inhibitor | Protein kinase C (PKC) inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
FAMITINIB,CHEMBL1278146,Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O
FEDRATINIB,CHEMBL1287853,Tyrosine-protein kinase receptor FLT3 inhibitor,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
MASITINIB,CHEMBL1908391,Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
PACRITINIB,CHEMBL2035187,Tyrosine-protein kinase receptor FLT3 inhibitor,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2
QUIZARTINIB DIHYDROCHLORIDE,CHEMBL2105709,Tyrosine-protein kinase receptor FLT3 inhibitor,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1.Cl.Cl
CRENOLANIB,CHEMBL2105728,Platelet-derived growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor,CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
GILTERITINIB FUMARATE,CHEMBL3301603,Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor UFO inhibitor,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O
GILTERITINIB,CHEMBL3301622,Tyrosine-protein kinase receptor FLT3 inhibitor | Tyrosine-protein kinase receptor UFO inhibitor,CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1
RUSERONTINIB,CHEMBL3678958,Epidermal growth factor receptor erbB1 inhibitor | Tyrosine-protein kinase ABL inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor,CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21
ALECTINIB HYDROCHLORIDE,CHEMBL3707320,Tyrosine-protein kinase receptor RET inhibitor,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O.Cl
PEXIDARTINIB,CHEMBL3813873,Macrophage colony stimulating factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
PEXIDARTINIB HYDROCHLORIDE,CHEMBL3989973,Macrophage colony stimulating factor receptor inhibitor | Stem cell growth factor receptor inhibitor | Tyrosine-protein kinase receptor FLT3 inhibitor,Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
AVAPRITINIB,CHEMBL4204794,Stem cell growth factor receptor inhibitor,Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
RIPRETINIB,CHEMBL4216467,Stem cell growth factor receptor inhibitor,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21
FEDRATINIB HYDROCHLORIDE,CHEMBL4297216,Tyrosine-protein kinase receptor FLT3 inhibitor,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O
SELPERCATINIB,CHEMBL4559134,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor | Tyrosine-protein kinase receptor RET inhibitor,COc1ccc(CN2C3CC2CN(c2ccc(-c4cc(OCC(C)(C)O)cn5ncc(C#N)c45)cn2)C3)cn1
PRALSETINIB,CHEMBL4582651,Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET inhibitor | Tyrosine-protein kinase receptor RET inhibitor,CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1
SERALUTINIB,CHEMBL4650333,Macrophage colony stimulating factor receptor inhibitor | Platelet-derived growth factor receptor inhibitor | Stem cell growth factor receptor inhibitor,COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC
PACRITINIB CITRATE,CHEMBL5095049,Tyrosine-protein kinase receptor FLT3 inhibitor,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O
LOMUSTINE,CHEMBL514,DNA inhibitor,O=NN(CCCl)C(=O)NC1CCCCC1
NITROFURANTOIN,CHEMBL572,DNA inhibitor,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1
METRONIDAZOLE,CHEMBL137,DNA inhibitor,Cc1ncc([N+](=O)[O-])n1CCO
LAMIVUDINE,CHEMBL141,DNA inhibitor,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1
BUSULFAN,CHEMBL820,DNA inhibitor,CS(=O)(=O)OCCCCOS(C)(=O)=O
NITROFURAZONE,CHEMBL869,DNA inhibitor,NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1
GENTIAN VIOLET,CHEMBL64894,DNA inhibitor,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
FURAZOLIDONE,CHEMBL1103,DNA inhibitor,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1
OXALIPLATIN,CHEMBL414804,DNA inhibitor,
CARBOPLATIN,CHEMBL1351,DNA inhibitor,
BRIVANIB,CHEMBL377300,Vascular endothelial growth factor receptor inhibitor,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1
ALTRETAMINE,CHEMBL1455,DNA inhibitor,CN(C)c1nc(N(C)C)nc(N(C)C)n1
URACIL MUSTARD,CHEMBL1488,DNA inhibitor,Oc1ncc(N(CCCl)CCCl)c(O)n1
AZATHIOPRINE,CHEMBL1542,Amidophosphoribosyltransferase inhibitor | DNA inhibitor,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12
BRIVANIB ALANINATE,CHEMBL270995,Vascular endothelial growth factor receptor inhibitor,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1
DACTINOMYCIN,CHEMBL1554,DNA inhibitor,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O
AZATHIOPRINE SODIUM,CHEMBL1200400,Amidophosphoribosyltransferase inhibitor | DNA inhibitor,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[n-]c12.[Na+]
CHLOROXINE,CHEMBL1200596,DNA inhibitor,Oc1c(Cl)cc(Cl)c2cccnc12
MERCAPTOPURINE,CHEMBL1200751,Amidophosphoribosyltransferase inhibitor | DNA inhibitor,O.S=c1[nH]cnc2nc[nH]c12
CYCLOPHOSPHAMIDE,CHEMBL1200796,DNA inhibitor,O.O=P1(N(CCCl)CCCl)NCCCO1
METRONIDAZOLE HYDROCHLORIDE,CHEMBL1200869,DNA inhibitor,Cc1ncc([N+](=O)[O-])n1CCO.Cl
EPIRUBICIN HYDROCHLORIDE,CHEMBL1200981,DNA inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl
NITROFURANTOIN SODIUM,CHEMBL1201000,DNA inhibitor,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)[N-]1.[Na+]
MECHLORETHAMINE HYDROCHLORIDE,CHEMBL1201001,DNA inhibitor,CN(CCCl)CCCl.Cl
METHENAMINE HIPPURATE,CHEMBL1201104,DNA inhibitor,C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1
NELARABINE,CHEMBL1201112,DNA inhibitor,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
BENDAMUSTINE HYDROCHLORIDE,CHEMBL1201734,DNA inhibitor,Cl.Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21
PLICAMYCIN,CHEMBL1237054,DNA inhibitor,CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1Cc2cc3cc(O[C@H]4C[C@@H](O[C@@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@@H]2C[C@@H](O)[C@@H](O[C@@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@H](O)[C@@H](C)O1
TIVOZANIB,CHEMBL1289494,Vascular endothelial growth factor receptor inhibitor,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
AXITINIB,CHEMBL1289926,Vascular endothelial growth factor receptor inhibitor,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1
STREPTOZOCIN,CHEMBL1977579,DNA inhibitor,CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO
LENVATINIB MESYLATE,CHEMBL2105704,Vascular endothelial growth factor receptor inhibitor,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O
NINTEDANIB ESYLATE,CHEMBL3039504,Platelet-derived growth factor receptor inhibitor | Vascular endothelial growth factor receptor inhibitor,CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1
SURUFATINIB,CHEMBL4297190,Vascular endothelial growth factor receptor inhibitor,Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1
FRUQUINTINIB,CHEMBL4303214,Vascular endothelial growth factor receptor inhibitor,CNC(=O)c1c(C)oc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12
IBCASERTIB,CHEMBL5095033,Vascular endothelial growth factor receptor inhibitor,COc1ccc2c(Oc3ccc4c(C(=O)Nc5ccccc5N)cccc4c3)ccnc2c1
METHOXSALEN,CHEMBL416,DNA inhibitor,COc1c2occc2cc2ccc(=O)oc12
DACARBAZINE,CHEMBL476,DNA inhibitor,CN(C)/N=N/c1[nH]cnc1C(N)=O
CISPLATIN,CHEMBL11359,DNA inhibitor,
CARMUSTINE,CHEMBL513,DNA inhibitor | RNA inhibitor,O=NN(CCCl)C(=O)NCCCl
CHLORAMBUCIL,CHEMBL515,DNA inhibitor,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1
MITOMYCIN,CHEMBL105,DNA inhibitor,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12
THIOTEPA,CHEMBL671,DNA inhibitor,S=P(N1CC1)(N1CC1)N1CC1
THIOGUANINE,CHEMBL727,DNA inhibitor | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,Nc1nc2[nH]cnc2c(=S)[nH]1
IDOXURIDINE,CHEMBL788,DNA inhibitor,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I
TEMOZOLOMIDE,CHEMBL810,DNA inhibitor,Cn1nnc2c(C(N)=O)ncn2c1=O
OXAMNIQUINE,CHEMBL847,DNA inhibitor,CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1
MELPHALAN,CHEMBL852,DNA inhibitor,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O
VOSAROXIN,CHEMBL68117,DNA inhibitor | DNA topoisomerase II inhibitor,CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC
IFOSFAMIDE,CHEMBL1024,DNA inhibitor,O=P1(NCCCl)OCCCN1CCCl
APAZIQUONE,CHEMBL73822,DNA inhibitor,Cn1c(/C=C/CO)c(CO)c2c1C(=O)C=C(N1CC1)C2=O
TRIFLURIDINE,CHEMBL1129,DNA inhibitor,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F
IROFULVEN,CHEMBL118218,DNA inhibitor,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1
CLOFAZIMINE,CHEMBL1292,DNA inhibitor,CC(C)/N=c1\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1
PENTAMIDINE ISETHIONATE,CHEMBL361506,DNA inhibitor | Kinetoplast DNA inhibitor,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO
DAUNORUBICIN,CHEMBL178,DNA inhibitor | DNA topoisomerase II alpha inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
FLUOROURACIL,CHEMBL185,DNA inhibitor | RNA inhibitor,O=c1[nH]cc(F)c(=O)[nH]1
NICLOSAMIDE,CHEMBL1448,DNA inhibitor,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
TRIOXSALEN,CHEMBL1475,DNA inhibitor,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1
AZACITIDINE,CHEMBL1489,DNA (cytosine-5)-methyltransferase 1 inhibitor | DNA (cytosine-5)-methyltransferase 3A inhibitor | DNA inhibitor | RNA inhibitor,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
EVOFOSFAMIDE,CHEMBL260046,DNA inhibitor,Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]
DAUNORUBICIN HYDROCHLORIDE,CHEMBL1563,DNA inhibitor | DNA topoisomerase II alpha inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
PIPOBROMAN,CHEMBL1585,DNA inhibitor,O=C(CCBr)N1CCN(C(=O)CCBr)CC1
DOXORUBICIN HYDROCHLORIDE,CHEMBL359744,DNA inhibitor | DNA topoisomerase II alpha inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
CLADRIBINE,CHEMBL1619,DNA inhibitor,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
TRABECTEDIN,CHEMBL450449,DNA inhibitor,COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4
CAPECITABINE,CHEMBL1773,DNA inhibitor | RNA inhibitor,CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F
VALRUBICIN,CHEMBL1096885,DNA inhibitor | DNA topoisomerase II alpha inhibitor,CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
PROCARBAZINE HYDROCHLORIDE,CHEMBL1200410,DNA inhibitor,CNNCc1ccc(C(=O)NC(C)C)cc1.Cl
DAUNORUBICIN CITRATE,CHEMBL1200475,DNA inhibitor | DNA topoisomerase II alpha inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=C(O)CC(O)(CC(=O)O)C(=O)O
AMINOLEVULINIC ACID HYDROCHLORIDE,CHEMBL1200582,DNA inhibitor,Cl.NCC(=O)CCC(=O)O
ESTRAMUSTINE PHOSPHATE SODIUM,CHEMBL1200721,DNA inhibitor,C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)([O-])[O-].[Na+].[Na+]
MELPHALAN HYDROCHLORIDE,CHEMBL1200863,DNA inhibitor,Cl.N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O
IDARUBICIN HYDROCHLORIDE,CHEMBL1200976,DNA inhibitor | DNA topoisomerase II alpha inhibitor,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl
METHYL AMINOLEVULINATE HYDROCHLORIDE,CHEMBL1201093,DNA inhibitor,COC(=O)CCC(=O)CN.Cl
DECITABINE,CHEMBL1201129,DNA (cytosine-5)-methyltransferase 1 inhibitor | DNA (cytosine-5)-methyltransferase 3A inhibitor | DNA inhibitor,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1
PORFIMER SODIUM,CHEMBL1201481,DNA inhibitor,
MITOXANTRONE HYDROCHLORIDE,CHEMBL1417019,DNA inhibitor | DNA topoisomerase II alpha inhibitor,Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21
HYDROXYSTILBAMIDINE ISETHIONATE,CHEMBL2023895,DNA inhibitor | RNA inhibitor,N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO
ELACYTARABINE,CHEMBL2105665,DNA inhibitor | RNA inhibitor,CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O
SAPACITABINE,CHEMBL2105681,DNA inhibitor,CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1
PAFURAMIDINE MALEATE,CHEMBL2107359,Kinetoplast DNA inhibitor,CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1.O=C(O)/C=C\C(=O)O
VERTEPORFIN,CHEMBL5314346,DNA inhibitor,
BLEOMYCIN SULFATE,CHEMBL6067493,DNA inhibitor,
MECHLORETHAMINE,CHEMBL427,DNA inhibitor,CN(CCCl)CCCl
AMSACRINE,CHEMBL43,DNA topoisomerase II inhibitor,COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12
CLIOQUINOL,CHEMBL497,Iron chelating agent,Oc1c(I)cc(Cl)c2cccnc12
TEGAFUR,CHEMBL20883,DNA inhibitor | RNA inhibitor,O=c1[nH]c(=O)n(C2CCCO2)cc1F
BETAMETHASONE,CHEMBL632,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
PREDNISONE,CHEMBL635,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
PREDNISOLONE,CHEMBL131,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
NIFURTIMOX,CHEMBL290960,DNA inhibitor,CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1
ETOPOSIDE,CHEMBL44657,DNA topoisomerase II inhibitor,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
DEFEROXAMINE MESYLATE,CHEMBL1234,Iron chelating agent,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O
CICLOPIROX,CHEMBL1413,Iron chelating agent,Cc1cc(C2CCCCC2)n(O)c(=O)c1
HYDROCORTISONE,CHEMBL389621,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
PAZUFLOXACIN,CHEMBL240163,DNA topoisomerase II inhibitor,C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
TRIAMCINOLONE ACETONIDE,CHEMBL1504,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
FLUNISOLIDE,CHEMBL1512,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
HYDROCORTISONE CYPIONATE,CHEMBL1549,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1
TENIPOSIDE,CHEMBL452231,DNA topoisomerase II inhibitor,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](c6cccs6)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
AMRUBICIN HYDROCHLORIDE,CHEMBL481958,DNA topoisomerase II alpha inhibitor,CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O.Cl
SECNIDAZOLE,CHEMBL498847,DNA inhibitor,Cc1ncc([N+](=O)[O-])n1CC(C)O
DEFERASIROX,CHEMBL550348,Iron chelating agent,O=C(O)c1ccc(-n2nc(-c3ccccc3O)nc2-c2ccccc2O)cc1
DEXRAZOXANE,CHEMBL1738,DNA topoisomerase II inhibitor | Iron sequestering agent,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1
CLOBETASOL PROPIONATE,CHEMBL1159650,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
AMRUBICIN,CHEMBL1186894,DNA topoisomerase II alpha inhibitor,CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O
PARAMETHASONE ACETATE,CHEMBL1200342,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
BETAMETHASONE DIPROPIONATE,CHEMBL1200384,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
PREDNICARBATE,CHEMBL1200386,Glucocorticoid receptor agonist,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
HYDROCORTISONE SODIUM SUCCINATE,CHEMBL1200495,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]
BECLOMETHASONE DIPROPIONATE,CHEMBL1200500,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
BETAMETHASONE ACETATE,CHEMBL1200538,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
DIFLORASONE DIACETATE,CHEMBL1200545,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
FLUOROMETHOLONE,CHEMBL1200600,Glucocorticoid receptor agonist,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTAMATE HYDROCHLORIDE,CHEMBL1200635,Glucocorticoid receptor agonist,CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl
ETOPOSIDE PHOSPHATE,CHEMBL1200645,DNA topoisomerase II alpha inhibitor,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OP(=O)(O)O
BETAMETHASONE SODIUM PHOSPHATE,CHEMBL1200762,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
DEXRAZOXANE HYDROCHLORIDE,CHEMBL1200778,DNA topoisomerase II inhibitor | Iron chelating agent,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1.Cl
HALCINONIDE,CHEMBL1200845,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
LOTEPREDNOL ETABONATE,CHEMBL1200865,Glucocorticoid receptor agonist,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
FLUMETHASONE PIVALATE,CHEMBL1200877,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C
HALOBETASOL PROPIONATE,CHEMBL1200908,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
PREDNISOLONE TEBUTATE,CHEMBL1200909,Glucocorticoid receptor agonist,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
HYDROCORTISONE SODIUM PHOSPHATE,CHEMBL1200968,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
METHYLPREDNISOLONE SODIUM SUCCINATE,CHEMBL1201081,Glucocorticoid receptor agonist,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+]
DESONIDE,CHEMBL1201109,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
MEDRYSONE,CHEMBL1201173,Glucocorticoid receptor agonist,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
DIFLUPREDNATE,CHEMBL1201749,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
DEXAMETHASONE SODIUM PHOSPHATE,CHEMBL2021430,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
BECATECARIN,CHEMBL2107313,DNA topoisomerase II inhibitor,CCN(CC)CCN1C(=O)c2c(c3c4cccc(Cl)c4n([C@@H]4O[C@H](CO)[C@@H](OC)[C@H](O)[C@H]4O)c3c3[nH]c4c(Cl)cccc4c23)C1=O
ALDOXORUBICIN,CHEMBL2107818,DNA topoisomerase II alpha inhibitor,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
METHYLPREDNISOLONE,CHEMBL650,Glucocorticoid receptor agonist,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12
FLUOCINOLONE ACETONIDE,CHEMBL989,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
HYDROCORTISONE ACETATE,CHEMBL1091,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
PREDNISOLONE ACETATE,CHEMBL1152,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
MOMETASONE FUROATE,CHEMBL1161,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
BUDESONIDE,CHEMBL1370,Glucocorticoid receptor agonist,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
DEXAMETHASONE,CHEMBL384467,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
TRIAMCINOLONE,CHEMBL1451,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F
FLUTICASONE PROPIONATE,CHEMBL1473,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
BETAMETHASONE VALERATE,CHEMBL1497,Glucocorticoid receptor agonist,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
FLUOCINONIDE,CHEMBL1501,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
CORTISONE ACETATE,CHEMBL1650,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C
FLUTICASONE FUROATE,CHEMBL1676,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF
HYDROCORTISONE BUTYRATE,CHEMBL1683,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
DESOXIMETASONE,CHEMBL1766,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO
BETAMETHASONE BENZOATE,CHEMBL1200376,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO
TRIAMCINOLONE DIACETATE,CHEMBL1200449,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTISONE VALERATE,CHEMBL1200562,Glucocorticoid receptor agonist,CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
RIMEXOLONE,CHEMBL1200617,Glucocorticoid receptor agonist,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
AMCINONIDE,CHEMBL1200732,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
FLUPREDNISOLONE,CHEMBL1200774,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
OXYMORPHONE HYDROCHLORIDE,CHEMBL1200794,Opioid receptors; mu/kappa/delta agonist,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl
TRIAMCINOLONE HEXACETONIDE,CHEMBL1200878,Glucocorticoid receptor agonist,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
HYDROCORTISONE PROBUTATE,CHEMBL1200953,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
CLOCORTOLONE PIVALATE,CHEMBL1200975,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C
ALCLOMETASONE DIPROPIONATE,CHEMBL1200989,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
FLURANDRENOLIDE,CHEMBL1201012,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
PREDNISOLONE SODIUM PHOSPHATE,CHEMBL1201014,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
FLUOROMETHOLONE ACETATE,CHEMBL1201064,Glucocorticoid receptor agonist,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
NALBUPHINE HYDROCHLORIDE,CHEMBL1201132,Opioid receptors; mu/kappa/delta agonist,Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314
MEPREDNISONE,CHEMBL1201148,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO
ALDESLEUKIN,CHEMBL1201438,Interleukin-2 receptor agonist,
CODEINE POLISTIREX,CHEMBL1201463,Opioid receptors; mu/kappa/delta agonist,
HYDROCODONE POLISTIREX,CHEMBL1201470,Opioid receptors; mu/kappa/delta agonist,
GEMTUZUMAB OZOGAMICIN,CHEMBL1201506,DNA disrupting agent | Myeloid cell surface antigen CD33 binding agent,
DEFLAZACORT,CHEMBL1201891,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
METHYLPREDNISOLONE ACETATE,CHEMBL1364144,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
DEXAMETHASONE ACETATE,CHEMBL1530428,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
CICLESONIDE,CHEMBL2040682,Glucocorticoid receptor agonist,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
MAPRACORAT,CHEMBL2103876,Glucocorticoid receptor agonist,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1
VAMOROLONE,CHEMBL2348780,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO
CEBRANOPADOL,CHEMBL2364605,Opioid receptors; mu/kappa/delta agonist,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12
BENZHYDROCODONE HYDROCHLORIDE,CHEMBL3137310,Opioid receptors; mu/kappa/delta agonist,COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341.Cl
HYDROCODONE BITARTRATE,CHEMBL3989677,Opioid receptors; mu/kappa/delta agonist,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O
CODEINE SULFATE,CHEMBL4297091,Opioid receptors; mu/kappa/delta agonist,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.O.O.O.O=S(=O)(O)O
CODEINE PHOSPHATE,CHEMBL6067642,Opioid receptors; mu/kappa/delta agonist,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.O.O=P(O)(O)O.O=P(O)(O)O
BISANTRENE,CHEMBL25336,DNA disrupting agent,C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12
TIRAPAZAMINE,CHEMBL50882,DNA disrupting agent,Nc1n[n+]([O-])c2ccccc2[n+]1[O-]
DOXIFLURIDINE,CHEMBL1130,DNA disrupting agent,C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O
TINIDAZOLE,CHEMBL1220,DNA disrupting agent,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C
EPOETIN ALFA,CHEMBL1201565,Erythropoietin receptor agonist,
PEGFILGRASTIM,CHEMBL1201568,Granulocyte colony stimulating factor receptor agonist,
FILGRASTIM,CHEMBL1201567,Granulocyte colony stimulating factor receptor agonist,
DARBEPOETIN ALFA,CHEMBL1201566,Erythropoietin receptor agonist,
SARGRAMOSTIM,CHEMBL1201670,Granulocyte-macrophage colony-stimulating factor receptor agonist,
ALEMTUZUMAB,CHEMBL1201587,CAMPATH-1 antigen inhibitor,
PEVONEDISTAT,CHEMBL1231160,NEDD8 activating enzyme inhibitor,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O
PEGINESATIDE ACETATE,CHEMBL1963684,Erythropoietin receptor agonist,
GLUFOSFAMIDE,CHEMBL2107143,DNA disrupting agent,O=P(NCCCl)(NCCCl)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
PEGINESATIDE,CHEMBL2107866,Erythropoietin receptor agonist,
REGRAMOSTIM,CHEMBL2107881,Granulocyte colony stimulating factor receptor agonist,
EPOETIN THETA,CHEMBL2108290,Erythropoietin receptor agonist,
GEMTUZUMAB,CHEMBL2108342,Myeloid cell surface antigen CD33 binding agent,
EPOETIN ZETA,CHEMBL2108593,Erythropoietin receptor agonist,
INOTUZUMAB OZOGAMICIN,CHEMBL2108611,DNA disrupting agent,
EPOETIN BETA,CHEMBL2109092,Erythropoietin receptor agonist,
EPOETIN DELTA,CHEMBL2109093,Erythropoietin receptor agonist,
LENOGRASTIM,CHEMBL2109128,Granulocyte colony stimulating factor receptor agonist,
CANFOSFAMIDE,CHEMBL2111086,DNA disrupting agent,N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(=O)O)c1ccccc1)C(=O)O
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,CHEMBL3707314,Erythropoietin receptor agonist,
EFLAPEGRASTIM,CHEMBL3833384,Granulocyte colony stimulating factor receptor agonist,
EFBEMALENOGRASTIM ALFA,CHEMBL4297950,Granulocyte colony stimulating factor receptor agonist,
TRASTUZUMAB DUOCARMAZINE,CHEMBL4298178,DNA disrupting agent,
LIPEGFILGRASTIM,CHEMBL4594230,Granulocyte colony stimulating factor receptor agonist,
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,CHEMBL4594406,DNA disrupting agent,
EFEPOETIN ALFA,CHEMBL4594471,Erythropoietin receptor agonist,
ORANTINIB,CHEMBL274654,Platelet-derived growth factor receptor inhibitor | Vascular endothelial growth factor receptor 2 inhibitor,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O
BOSUTINIB,CHEMBL288441,Tyrosine-protein kinase ABL inhibitor | Tyrosine-protein kinase SRC inhibitor,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
MYCOPHENOLIC ACID,CHEMBL866,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2
CYCLOSPORINE,CHEMBL160,Cyclophilin A modulator,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
SARACATINIB,CHEMBL217092,Tyrosine-protein kinase ABL inhibitor | Tyrosine-protein kinase SRC inhibitor,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1
MYCOPHENOLATE MOFETIL,CHEMBL1456,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2
MIZORIBINE,CHEMBL245019,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O
RIBAVIRIN,CHEMBL1643,RNA inhibitor,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1
PATIDEGIB,CHEMBL538867,Smoothened homolog antagonist,CC1=C2C[C@H]3[C@@H](CC[C@@H]4C[C@H](NS(C)(=O)=O)CC[C@@]43C)[C@@H]2CC[C@@]2(C1)O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
TIRBANIBULIN,CHEMBL571546,Tyrosine-protein kinase SRC inhibitor,O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1
MYCOPHENOLATE MOFETIL HYDROCHLORIDE,CHEMBL1200955,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2.Cl
NILOTINIB HYDROCHLORIDE MONOHYDRATE,CHEMBL1201740,Bcr/Abl fusion protein inhibitor | Tyrosine-protein kinase ABL inhibitor,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O
VOLASERTIB,CHEMBL1233528,Serine/threonine-protein kinase PLK1 inhibitor,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C
GLASDEGIB,CHEMBL2043437,Smoothened homolog antagonist,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1
BOSUTINIB MONOHYDRATE,CHEMBL2095206,Bcr/Abl fusion protein inhibitor,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl.O
PONATINIB HYDROCHLORIDE,CHEMBL2105708,Bcr/Abl fusion protein inhibitor,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl
MYCOPHENOLATE SODIUM,CHEMBL2106643,Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)[O-])C(=O)OC2.[Na+]
VISILIZUMAB,CHEMBL2108811,T-cell surface glycoprotein CD3 epsilon chain inhibitor,
OBLIMERSEN SODIUM,CHEMBL2109229,Bcl-2 mRNA antisense inhibitor,
HOKT3,CHEMBL2109253,T-cell surface glycoprotein CD3 epsilon chain inhibitor,
ABAMETAPIR,CHEMBL2205807,Iron sequestering agent,Cc1ccc(-c2ccc(C)cn2)nc1
OLVEREMBATINIB,CHEMBL2316582,Bcr/Abl fusion protein inhibitor,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1
NAVTEMADLIN,CHEMBL3125702,Tumour suppressor p53/oncoprotein Mdm2 inhibitor,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1
FLUMATINIB,CHEMBL3545413,Tyrosine-protein kinase ABL inhibitor,Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1
UMBRALISIB TOSYLATE,CHEMBL3989869,Tyrosine-protein kinase ABL inhibitor,CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1
ASCIMINIB,CHEMBL4208229,Tyrosine-protein kinase ABL inhibitor,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
ASCIMINIB HYDROCHLORIDE,CHEMBL4297220,Bcr/Abl fusion protein inhibitor,Cl.O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
RADOTINIB,CHEMBL4297524,Bcr/Abl fusion protein inhibitor,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1
GLASDEGIB MALEATE,CHEMBL4297534,Smoothened homolog antagonist,CN1CC[C@@H](NC(=O)Nc2ccc(C#N)cc2)C[C@@H]1c1nc2ccccc2[nH]1.O=C(O)/C=C\C(=O)O
DASATINIB,CHEMBL5416410,Bcr/Abl fusion protein inhibitor,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1.O
TRIMETHOPRIM,CHEMBL22,Bacterial dihydrofolate reductase inhibitor,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC
PYRIMETHAMINE,CHEMBL36,Dihydrofolate reductase inhibitor,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1
METHOTREXATE,CHEMBL34259,Dihydrofolate reductase inhibitor,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
TIPIFARNIB,CHEMBL289228,Protein farnesyltransferase inhibitor,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C
LONAFARNIB,CHEMBL298734,Protein farnesyltransferase inhibitor,NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1
GEFITINIB,CHEMBL939,Epidermal growth factor receptor erbB1 inhibitor,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1
CO-TRIMOXAZOLE,CHEMBL58061,Bacterial dihydrofolate reductase inhibitor,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1
AMINOSALICYLIC ACID,CHEMBL1169,Dihydrofolate reductase inhibitor,Nc1ccc(C(=O)O)c(O)c1
ICLAPRIM,CHEMBL134561,Bacterial dihydrofolate reductase inhibitor,COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)OC(C1CC1)C=C2
PEMETREXED,CHEMBL225072,Dihydrofolate reductase inhibitor,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1
NAVITOCLAX,CHEMBL443684,Apoptosis regulator Bcl-2 inhibitor,CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1
ERLOTINIB HYDROCHLORIDE,CHEMBL1079742,Epidermal growth factor receptor erbB1 inhibitor,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl
AMINOSALICYLATE POTASSIUM,CHEMBL1200584,Dihydrofolate reductase inhibitor,Nc1ccc(C(=O)[O-])c(O)c1.[K+]
PROGUANIL HYDROCHLORIDE,CHEMBL1201059,Dihydrofolate reductase inhibitor,CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1.Cl
TRIMETHOPRIM HYDROCHLORIDE,CHEMBL1201080,Bacterial dihydrofolate reductase inhibitor,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.Cl
CETUXIMAB,CHEMBL1201577,Epidermal growth factor receptor erbB1 inhibitor,
PRALATREXATE,CHEMBL1201746,Dihydrofolate reductase inhibitor,C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
PANITUMUMAB,CHEMBL1201827,Epidermal growth factor receptor erbB1 inhibitor,
AMINOSALICYLATE SODIUM,CHEMBL2096646,Dihydrofolate reductase inhibitor,Nc1ccc(C(=O)[O-])c(O)c1.O.O.[Na+]
FOSTAMATINIB,CHEMBL2103830,Tyrosine-protein kinase SYK inhibitor,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC
OBATOCLAX MESYLATE,CHEMBL2107358,Apoptosis regulator Bcl-2 inhibitor,COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1[nH]c(C)cc1C.CS(=O)(=O)O
TRIMETHOPRIM SULFATE,CHEMBL2110367,Bacterial dihydrofolate reductase inhibitor,COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.O=S(=O)(O)O
TRIMETREXATE GLUCURONATE,CHEMBL2218878,Dihydrofolate reductase inhibitor,COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O
PEMETREXED DISODIUM,CHEMBL2360464,Dihydrofolate reductase inhibitor,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+]
IDASANUTLIN,CHEMBL2402737,Tumour suppressor p53/oncoprotein Mdm2 inhibitor,COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F
VENETOCLAX,CHEMBL3137309,Apoptosis regulator Bcl-2 inhibitor,CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1
METHOTREXATE SODIUM,CHEMBL3244648,Dihydrofolate reductase inhibitor,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Na+].[Na+]
ENTOSPLETINIB,CHEMBL3265032,Tyrosine-protein kinase SYK inhibitor,c1cn2cc(-c3ccc4cn[nH]c4c3)nc(Nc3ccc(N4CCOCC4)cc3)c2n1
SELINEXOR,CHEMBL3545185,Exportin-1 inhibitor,O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1
FOSTAMATINIB DISODIUM,CHEMBL3989516,Tyrosine-protein kinase SYK inhibitor,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]
PEMETREXED TROMETHAMINE,CHEMBL3989962,Dihydrofolate reductase inhibitor,NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1.O.O
SOVLEPLENIB,CHEMBL5095034,Tyrosine-protein kinase SYK inhibitor,CS(=O)(=O)N1CCC(c2ccc(-c3ncc4nccnc4c3NC[C@@H]3CNCCO3)cc2)CC1
PEMETREXED MONOHYDRATE,CHEMBL5315053,Dihydrofolate reductase inhibitor,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1.O
PEMETREXED DIPOTASSIUM,CHEMBL6068329,Dihydrofolate reductase inhibitor,Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[K+].[K+]
NERATINIB,CHEMBL180022,Epidermal growth factor receptor erbB1 inhibitor,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C
CANERTINIB DIHYDROCHLORIDE,CHEMBL545315,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl
LAPATINIB DITOSYLATE,CHEMBL1201179,Epidermal growth factor receptor erbB1 inhibitor,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O
NECITUMUMAB,CHEMBL1743047,Epidermal growth factor receptor erbB1 inhibitor,
ICOTINIB,CHEMBL2087361,Epidermal growth factor receptor erbB1 inhibitor,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1
AFATINIB DIMALEATE,CHEMBL2105712,Epidermal growth factor receptor erbB1 inhibitor,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O
DACOMITINIB,CHEMBL2105719,Epidermal growth factor receptor erbB1 inhibitor,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O
NIMOTUZUMAB,CHEMBL2108359,Epidermal growth factor receptor erbB1 inhibitor,
DACOMITINIB ANHYDROUS,CHEMBL2110732,Epidermal growth factor receptor erbB1 inhibitor,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1
OSIMERTINIB,CHEMBL3353410,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
TESEVATINIB,CHEMBL3544983,Epidermal growth factor receptor erbB1 inhibitor,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1
OSIMERTINIB MESYLATE,CHEMBL3545063,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O
SIMOTINIB,CHEMBL3545235,Epidermal growth factor receptor erbB1 inhibitor,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CC2)C2(C1)OCCO2
ROCILETINIB,CHEMBL3545308,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1
BRIGATINIB,CHEMBL3545311,Epidermal growth factor receptor erbB1 inhibitor,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1
PYROTINIB,CHEMBL3647420,Epidermal growth factor receptor erbB1 inhibitor,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C
NAQUOTINIB,CHEMBL3663929,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1
OLMUTINIB,CHEMBL3786343,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1
NERATINIB MALEATE,CHEMBL3989921,Epidermal growth factor receptor erbB1 inhibitor,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C.O=C(O)/C=C\C(=O)O
FIRMONERTINIB,CHEMBL4297258,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC(F)(F)F)nc1N(C)CCN(C)C
ABIVERTINIB,CHEMBL4297865,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1
ABIVERTINIB MALEATE,CHEMBL4297866,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O
CLN-081,CHEMBL4650281,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1
AUMOLERTINIB,CHEMBL4761468,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
TRETINOIN,CHEMBL38,Retinoic acid receptor agonist,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1
PACLITAXEL,CHEMBL428647,Tubulin inhibitor,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
ISOTRETINOIN,CHEMBL547,Retinoic acid receptor agonist,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
COLCHICINE,CHEMBL107,Tubulin inhibitor,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
GRISEOFULVIN,CHEMBL562,Tubulin inhibitor,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
MEBENDAZOLE,CHEMBL685,Tubulin inhibitor,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
ADAPALENE,CHEMBL1265,Retinoic acid receptor agonist,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2
VINBLASTINE SULFATE,CHEMBL378544,Tubulin inhibitor,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
VINCRISTINE SULFATE,CHEMBL501867,Tubulin inhibitor,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
TAZAROTENE,CHEMBL1657,Retinoic acid receptor agonist,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1
VINORELBINE TARTRATE,CHEMBL538943,Tubulin inhibitor,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
DENILEUKIN DIFTITOX,CHEMBL1201550,Elongation factor 2 inhibitor,
CABAZITAXEL,CHEMBL1201748,Tubulin inhibitor,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
IXABEPILONE,CHEMBL1201752,Tubulin inhibitor,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
ERIBULIN MESYLATE,CHEMBL1683544,Tubulin inhibitor,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
BRENTUXIMAB VEDOTIN,CHEMBL1742994,Tubulin inhibitor,
MOXETUMOMAB PASUDOTOX,CHEMBL1743043,Elongation factor 2 inhibitor,
OPORTUZUMAB MONATOX,CHEMBL1743052,Elongation factor 2 inhibitor,
TRASTUZUMAB EMTANSINE,CHEMBL1743082,Tubulin inhibitor,
CINTREDEKIN BESUDOTOX,CHEMBL2108583,Elongation factor 2 inhibitor,
DOCETAXEL,CHEMBL3545252,Tubulin inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
RIVIPANSEL,CHEMBL3707446,Selectin E antagonist,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](NC(=O)c3cc(=O)[nH]c(=O)[nH]3)C[C@@H](C(=O)NCCNC(=O)COCCOCC(=O)Nc3cc(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(S(=O)(=O)O)c34)C[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2OC(=O)c2ccccc2)[C@@H](O)[C@H](O)[C@@H]1O
GALINPEPIMUT-S,CHEMBL3833386,Wilms tumor protein vaccine antigen,
ENASIDENIB MESYLATE,CHEMBL3989931,"Isocitrate dehydrogenase [NADP], mitochondrial inhibitor",CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1.CS(=O)(=O)O
IVOSIDENIB,CHEMBL3989958,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,N#Cc1ccnc(N2C(=O)CC[C@H]2C(=O)N(c2cncc(F)c2)[C@H](C(=O)NC2CC(F)(F)C2)c2ccccc2Cl)c1
UPROLESELAN,CHEMBL3989971,Selectin E antagonist,CC[C@H]1C[C@@H](C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O
MODOTUXIMAB,CHEMBL3989988,Epidermal growth factor receptor erbB1 inhibitor,
OMBIPEPIMUT-S,CHEMBL4297235,Wilms tumor protein vaccine antigen,
TAGRAXOFUSP,CHEMBL4297573,Elongation factor 2 inhibitor | Interleukin-3 receptor subunit alpha binding agent,
OLUTASIDENIB,CHEMBL4297610,Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor,C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O
AMIVANTAMAB,CHEMBL4297774,Epidermal growth factor receptor erbB1 inhibitor,
MAGROLIMAB,CHEMBL4297985,Leukocyte surface antigen CD47 inhibitor,
LAZERTINIB,CHEMBL4558324,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1
MOBOCERTINIB,CHEMBL4650319,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C
MOBOCERTINIB SUCCINATE,CHEMBL4802239,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.O=C(O)CCC(=O)O
LAZERTINIB MESYLATE,CHEMBL6068478,Epidermal growth factor receptor erbB1 inhibitor,C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1.CS(=O)(=O)O.O
THIABENDAZOLE,CHEMBL625,Tubulin inhibitor,c1ccc2[nH]c(-c3cscn3)nc2c1
ALBENDAZOLE,CHEMBL1483,Tubulin inhibitor,CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1
OMBRABULIN,CHEMBL572284,Tubulin inhibitor,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
ANG1005,CHEMBL1089636,Tubulin inhibitor,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
PLINABULIN,CHEMBL1096380,Tubulin inhibitor,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
VINFLUNINE DITARTRATE,CHEMBL2105629,Tubulin inhibitor,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
VINFLUNINE,CHEMBL2110725,Tubulin inhibitor,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
POLATUZUMAB VEDOTIN,CHEMBL3301582,Tubulin inhibitor,
ENFORTUMAB VEDOTIN,CHEMBL3301589,Tubulin inhibitor,
MIRVETUXIMAB SORAVTANSINE,CHEMBL3545132,Tubulin inhibitor,
TELISOTUZUMAB VEDOTIN,CHEMBL3990032,Tubulin inhibitor,
TISOTUMAB VEDOTIN,CHEMBL4297841,Tubulin inhibitor,
TUSAMITAMAB RAVTANSINE,CHEMBL4298098,Tubulin inhibitor,
BELANTAMAB MAFODOTIN,CHEMBL4298209,Tubulin inhibitor,
SERTINDOLE,CHEMBL12713,Adrenergic receptor alpha-1 antagonist,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CARVEDILOL,CHEMBL723,Adrenergic receptor alpha-1 antagonist | Adrenergic receptor beta antagonist,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
BUNAZOSIN,CHEMBL188185,Adrenergic receptor alpha-1 antagonist,CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1
PRAZOSIN HYDROCHLORIDE,CHEMBL1558,Adrenergic receptor alpha-1 antagonist,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl
DOXAZOSIN MESYLATE,CHEMBL1200561,Adrenergic receptor alpha-1 antagonist,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O
TAMSULOSIN HYDROCHLORIDE,CHEMBL1200914,Adrenergic receptor alpha-1 antagonist,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl
TRIMIPRAMINE MALEATE,CHEMBL1200948,Adrenergic receptor alpha-1 antagonist,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O
CARTEOLOL HYDROCHLORIDE,CHEMBL1201002,Adrenergic receptor beta antagonist,CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2.Cl
CARVEDILOL PHOSPHATE,CHEMBL1201167,Adrenergic receptor alpha-1 antagonist | Adrenergic receptor beta antagonist,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O
DILEVALOL HYDROCHLORIDE,CHEMBL1204165,Adrenergic receptor beta antagonist,C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl
RAMUCIRUMAB,CHEMBL1743062,Vascular endothelial growth factor receptor 2 inhibitor,
CABOZANTINIB S-MALATE,CHEMBL2103868,Vascular endothelial growth factor receptor 2 inhibitor,COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC.O=C(O)C[C@H](O)C(=O)O
EMACTUZUMAB,CHEMBL3545370,Macrophage colony stimulating factor receptor inhibitor,
RIVOCERANIB MESYLATE,CHEMBL3545414,Vascular endothelial growth factor receptor 2 inhibitor,CS(=O)(=O)O.N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1
DEPATUXIZUMAB MAFODOTIN,CHEMBL3707277,Tubulin inhibitor,
TERAZOSIN HYDROCHLORIDE,CHEMBL3989562,Adrenergic receptor alpha-1 antagonist,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O
AXATILIMAB,CHEMBL4594608,Macrophage colony stimulating factor receptor inhibitor,
THALIDOMIDE,CHEMBL468,CRL4(CRBN) E3 ubiquitin ligase inhibitor,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
VORINOSTAT,CHEMBL98,Histone deacetylase 1 inhibitor | Histone deacetylase 2 inhibitor | Histone deacetylase 3 inhibitor | Histone deacetylase 6 inhibitor,O=C(CCCCCCC(=O)Nc1ccccc1)NO
POMALIDOMIDE,CHEMBL43452,CRL4(CRBN) E3 ubiquitin ligase inhibitor,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
LENALIDOMIDE,CHEMBL848,CRL4(CRBN) E3 ubiquitin ligase inhibitor,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
